Accuray (ARAY) SEC Filings: History & Chart

Accuray Incorporated(ARAY)

Medical - Devices · Madison, WI

$0.30+0.02 (+7.37%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Accuray Incorporated

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

Madison, WI

809 employees

www.accuray.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stephen R. LaNeve

View full financials

Form	Filing Date	Accepted	Document
4	Oct 1, 2026	Oct 1, 2026	View filing
DEFA14A	Sep 18, 2026	Sep 18, 2026	View filing
EFFECT	Sep 11, 2026	Sep 14, 2026	View filing
424B3	Sep 11, 2026	Sep 11, 2026	View filing
S-3/A	Sep 9, 2026	Sep 9, 2026	View filing
SC 13D/A	Sep 2, 2026	Sep 2, 2026	View filing
4	Sep 2, 2026	Sep 2, 2026	View filing
10-K	Aug 27, 2026	Aug 27, 2026	View filing
DEF 14A	Aug 24, 2026	Aug 24, 2026	View filing
S-3/A	Aug 21, 2026	Aug 21, 2026	View filing
8-K	Aug 19, 2026	Aug 19, 2026	View filing
PRE 14A	Aug 12, 2026	Aug 12, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
SC 13G/A	Aug 5, 2026	Aug 5, 2026	View filing
S-3	Jul 31, 2026	Jul 31, 2026	View filing
8-K	Jul 29, 2026	Jul 29, 2026	View filing
SC 13G/A	Jul 27, 2026	Jul 27, 2026	View filing
SC 13G	Jul 7, 2026	Jul 7, 2026	View filing
8-K	Jun 4, 2026	Jun 4, 2026	View filing
4	May 29, 2026	May 29, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
S-8	May 29, 2026	May 29, 2026	View filing
SC 13D/A	May 22, 2026	May 22, 2026	View filing
4	May 21, 2026	May 21, 2026	View filing
10-Q	May 6, 2026	May 6, 2026	View filing
8-K	May 6, 2026	May 6, 2026	View filing
8-K	Apr 28, 2026	Apr 28, 2026	View filing
SC 13D/A	Apr 17, 2026	Apr 17, 2026	View filing
3	Apr 17, 2026	Apr 17, 2026	View filing
3	Apr 10, 2026	Apr 10, 2026	View filing

SEC Filings

Recent Filings